Prime Minister Imran Khan has ordered a probe into the alleged scandal of importing over 450 medicines like vitamin tablets in the guise of buying life-saving drugs from India, according to a media report.
On August 9, Pakistan suspended all trade ties with India following New Delhi's decision to abrogate Article 370 on August 5, revoking the special status of Jammu and Kashmir.
However, later the government allowed the import of life-saving drugs and their raw materials when the pharmaceutical industry created hue and cry and warned that soon Pakistan could face a shortage of important drugs.
There were repeated allegations by the Opposition and reports in the media that the relaxation given by the government was being misused and demands were made that a probe should be ordered.
Prompted by the reports, Prime Minister Khan tasked his aide on accountability Shahzad Akbar to probe the import of over 450 medicines from India.
A document of the Ministry of National Health Services (MNHS) shows that a number of vitamins, drugs and salts were imported from India, Dawn newspaper reported.
The document presented before the federal cabinet on May 5, states that the prime minister in his capacity as Minister In-charge for MNHS sought a list of drugs being imported from India.
The document, signed by MNHS Secretary Tanveer Ahmed Qureshi, shows that a number of vaccines, including BCG, Polio and Anti Tetanus Vaccine, have been imported. Moreover, a number of vitamins, including B1, B2, B6, B12, D3, Zinc Sulphate Monohydrate, were also being imported from India.
An official of the Drug Regulatory Authority of Pakistan, requesting not to be quoted, told the newspaper that initially it was claimed that cancer patients would suffer if import of medicines and their raw material from India were banned.
"However, later all kinds of medicines were imported from India due to which we have been transferring the foreign exchange to India. The government should ensure that the medicines and their raw materials are manufactured in Pakistan as it will allow us to save the precious foreign exchange and ensure export of medicines abroad, he said.
A senior officer of the MNHS, said that it was not appropriate to comment on it as Special Assistant to the Prime Minister on Accountability Akbar had been assigned to look into the issue, the report said.
Moreover, the Ministry of Commerce is also involved in it so we have decided to let Akbar look into the matter, he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
